Tetracyclic 1,4-Naphthoquinone Thioglucoside Conjugate U-556 Blocks the Purinergic P2X7 Receptor in Macrophages and Exhibits Anti-Inflammatory Activity In Vivo.

MLA

Kozlovskiy, Sergei, et al. “Tetracyclic 1,4-Naphthoquinone Thioglucoside Conjugate U-556 Blocks the Purinergic P2X7 Receptor in Macrophages and Exhibits Anti-Inflammatory Activity In Vivo.” International Journal of Molecular Sciences, vol. 24, no. 15, Aug. 2023, p. 12370. EBSCOhost, https://doi.org/10.3390/ijms241512370.

APA

Kozlovskiy, S., Pislyagin, E., Menchinskaya, E., Chingizova, E., Kaluzhskiy, L., Ivanov, A. S., Likhatskaya, G., Agafonova, I., Sabutski, Y., Polonik, S., Manzhulo, I., & Aminin, D. (2023). Tetracyclic 1,4-Naphthoquinone Thioglucoside Conjugate U-556 Blocks the Purinergic P2X7 Receptor in Macrophages and Exhibits Anti-Inflammatory Activity In Vivo. International Journal of Molecular Sciences, 24(15), 12370. https://doi.org/10.3390/ijms241512370

Chicago

Kozlovskiy, Sergei, Evgeny Pislyagin, Ekaterina Menchinskaya, Ekaterina Chingizova, Leonid Kaluzhskiy, Alexis S. Ivanov, Galina Likhatskaya, et al. 2023. “Tetracyclic 1,4-Naphthoquinone Thioglucoside Conjugate U-556 Blocks the Purinergic P2X7 Receptor in Macrophages and Exhibits Anti-Inflammatory Activity In Vivo.” International Journal of Molecular Sciences 24 (15): 12370. doi:10.3390/ijms241512370.